In addition, RhoA alterations could be associated with lymphovascular invasion, causing carcinomatous lymphangiosis or pulmonary tumor thrombotic microangiopathy in some extreme cases because RhoA is important in the transendothelial migration of neoplastic cells [27–29]. The gene discussed is RHOA; the disease is Genetic thrombotic microangiopathy.